Product NDC: | 49884-124 |
Proprietary Name: | Labetalol HCL |
Non Proprietary Name: | Labetalol Hydrochloride |
Active Ingredient(s): | 300 mg/1 & nbsp; Labetalol Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-124 |
Labeler Name: | Par Pharmaceutical Companies, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200908 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120724 |
Package NDC: | 49884-124-10 |
Package Description: | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49884-124-10) |
NDC Code | 49884-124-10 |
Proprietary Name | Labetalol HCL |
Package Description | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (49884-124-10) |
Product NDC | 49884-124 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Labetalol Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120724 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical Companies, Inc. |
Substance Name | LABETALOL HYDROCHLORIDE |
Strength Number | 300 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |